TTNP
Titan Pharmaceuticals
TTNP
TTNP
Delisted
TTNP was delisted on the 1st of October, 2025.
15 hedge funds and large institutions have $464K invested in Titan Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
60% less capital invested
Capital invested by funds: $1.15M → $464K (-$684K)
Holders
15
Holding in Top 10
–
Calls
$349K
Puts
$113K
Top Buyers
| 1 | +$60.2K | |
| 2 | +$59.8K | |
| 3 | +$55.7K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$26K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$19.6K |
Top Sellers
| 1 | -$803K | |
| 2 | -$32K | |
| 3 | -$6K | |
| 4 |
WIM
Westside Investment Management
Santa Monica,
California
|
-$1 |